Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis

被引:131
作者
Langford, Bradley J. [11 ,12 ]
Soucy, Jean-Paul R.
Leung, Valerie [1 ]
So, Miranda [2 ]
Kwan, Angela T. H. [3 ]
Portnoff, Jacob S. [4 ]
Bertagnolio, Silvia [5 ]
Raybardhan, Sumit [6 ]
MacFadden, Derek R. [3 ,7 ]
Daneman, Nick [8 ,9 ,10 ,11 ]
机构
[1] Publ Hlth Ontario, Toronto, ON, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Toronto East Hlth Network, Toronto, ON, Canada
[4] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[5] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[6] Univ Queensland, Fac Med, Brisbane, Qld, Australia
[7] WHO, Div Antimicrobial Resistance, Dept Surveillance Prevent & Control, Geneva, Switzerland
[8] North York Gen Hosp, Toronto, ON, Canada
[9] Ottawa Hosp, Ottawa, ON, Canada
[10] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[11] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[12] Publ Hlth Ontario, Hlth Protect, 480 Univ Ave, Toronto, ON 512, Canada
关键词
Antibiotic resistance; Antimicrobial resistance; Antimicrobial stewardship; COVID-19; Infection; Prevention and control; CARE-ASSOCIATED INFECTIONS; DISEASE; 2019; COVID-19; IMPACT; PREVENTION;
D O I
10.1016/j.cmi.2022.12.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: COVID-19 and antimicrobial resistance (AMR) are two intersecting global public health crises. Objective: We aimed to describe the impact of the COVID-19 pandemic on AMR across health care settings.Data source: A search was conducted in December 2021 in WHO COVID-19 Research Database with forward citation searching up to June 2022.Study eligibility: Studies evaluating the impact of COVID-19 on AMR in any population were included and influencing factors were extracted. Reporting of enhanced infection prevention and control and/or antimicrobial stewardship programs was noted.Methods: Pooling was done separately for Gram-negative and Gram-positive organisms. Random-effects meta-analysis was performed.Results: Of 6036 studies screened, 28 were included and 23 provided sufficient data for meta-analysis. The majority of studies focused on hospital settings (n 1/4 25, 89%). The COVID-19 pandemic was not associated with a change in the incidence density (incidence rate ratio 0.99, 95% CI: 0.67-1.47) or proportion (risk ratio 0.91, 95% CI: 0.55-1.49) of methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci cases. A non-statistically significant increase was noted for resistant Gram-negative organisms (i.e. extended-spectrum beta-lactamase, carbapenem-resistant Enterobacterales, carbapenem or multi-drug resistant or carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii, incidence rate ratio 1.64, 95% CI: 0.92-2.92; risk ratio 1.08, 95% CI: 0.91-1.29). The absence of reported enhanced infection prevention and control and/or antimicrobial stewardship programs initiatives was associated with an increase in gram-negative AMR (risk ratio 1.11, 95% CI: 1.03 -1.20). However, a test for subgroup differences showed no statistically significant difference between the presence and absence of these initiatives (p 0.40). Conclusion: The COVID-19 pandemic may have hastened the emergence and transmission of AMR, particularly for Gram-negative organisms in hospital settings. But there is considerable heterogeneity in both the AMR metrics used and the rate of resistance reported across studies. These findings reinforce the need for strengthened infection prevention, antimicrobial stewardship, and AMR surveillance in the context of the COVID-19 pandemic. Bradley J. Langford, Clin Microbiol Infect 2023;29:302 (c) 2022 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. This is an open access article under the CC BY IGO license (http://creativecommons.org/ licenses/by/3.0/igo/).
引用
收藏
页码:302 / 309
页数:8
相关论文
共 42 条
[1]   The Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated Infections [J].
Baker, Meghan A. ;
Sands, Kenneth E. ;
Huang, Susan S. ;
Kleinman, Ken ;
Septimus, Edward J. ;
Varma, Neha ;
Blanchard, Jackie ;
Poland, Russell E. ;
Coady, Micaela H. ;
Yokoe, Deborah S. ;
Fraker, Sarah ;
Froman, Allison ;
Moody, Julia ;
Goldin, Laurel ;
Isaacs, Amanda ;
Kleja, Kacie ;
Korwek, Kimberly M. ;
Stelling, John ;
Clark, Adam ;
Platt, Richard ;
Perlin, Jonathan B. .
CLINICAL INFECTIOUS DISEASES, 2022, 74 (10) :1748-1754
[2]   Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? [J].
Belvisi, V. ;
Borgo, C. Del ;
Vita, S. ;
Redaelli, P. ;
Dolce, P. ;
Pacella, D. ;
Kertusha, B. ;
Carraro, A. ;
Marocco, R. ;
Masi, M. De ;
Mastroianni, C. ;
Lichtner, M. .
JOURNAL OF HOSPITAL INFECTION, 2021, 109 :29-31
[3]   Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study [J].
Bentivegna, Enrico ;
Luciani, Michelangelo ;
Arcari, Luca ;
Santino, Iolanda ;
Simmaco, Maurizio ;
Martelletti, Paolo .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (03) :1-8
[4]   Conduct and reporting of citation searching in Cochrane systematic reviews: A cross-sectional study [J].
Briscoe, Simon ;
Bethel, Alison ;
Rogers, Morwenna .
RESEARCH SYNTHESIS METHODS, 2020, 11 (02) :169-180
[5]   Trends in Outpatient Antibiotic Prescriptions in the United States During the COVID-19 Pandemic in 2020 [J].
Buehrle, Deanna J. ;
Wagener, Marilyn M. ;
Nguyen, M. Hong ;
Clancy, Cornelius J. .
JAMA NETWORK OPEN, 2021, 4 (09)
[6]  
Castro MG, 2022, NEW ENGL J MED, V4, P92
[7]   Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015-2020: COVID-19 Aftermath [J].
Chamieh, Amanda ;
Zgheib, Rita ;
El-Sawalhi, Sabah ;
Yammine, Laure ;
El-Hajj, Gerard ;
Zmerli, Omar ;
Afif, Claude ;
Rolain, Jean-Marc ;
Azar, Eid .
ANTIBIOTICS-BASEL, 2021, 10 (08)
[8]   PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates [J].
Clancy, Cornelius J. ;
Buehrle, Deanna J. ;
Nguyen, M. Hong .
JAC-ANTIMICROBIAL RESISTANCE, 2020, 2 (03)
[9]   CON: COVID-19 will not result in increased antimicrobial resistance prevalence [J].
Collignon, Peter ;
Beggs, John J. .
JAC-ANTIMICROBIAL RESISTANCE, 2020, 2 (03)
[10]   The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units [J].
Despotovic, Aleksa ;
Milosevic, Branko ;
Cirkovic, Andja ;
Vujovic, Ankica ;
Cucanic, Ksenija ;
Cucanic, Teodora ;
Stevanovic, Goran .
ANTIBIOTICS-BASEL, 2021, 10 (10)